Archive for the ‘china retractions’ Category
Sometimes we come across a real head-scratcher.
That happened this week, when we saw a retraction notice for a 2015 paper on gastric cancer in the International Journal of Clinical and Experimental Medicine, which only says the authors “made big mistakes” and contains two fairly significant typos.
Although there’s no sign of a retraction on PubMed, the table of contents for the latest issue of the journal lists the retraction — but includes no hyperlink to the notice. The only way to see it is via a Web cached version. Here’s the text:
One of the retracted papers in the Journal of Neurosurgery (JNS) had multiple problems that were “too extensive to revise,” according to the lengthy retraction notice, relating to issues with authorship, data analyses, and patient enrollment. The notice is signed by first author Hua Liu of the Nanjing Medical University in China.
Liu is also the first author of another recently retracted paper in Frontiers in Neuroscience, pulled for incorrectly categorizing patients.
An oncology journal has decided to retract a 2012 paper on gastric cancer after discovering duplicated data in multiple figures.
According to the retraction notice, the journal’s editorial board received a tip from a reader regarding the potential figure issues. Oncology Reports launched an investigation, which confirmed the allegations. The authors failed to respond to the journal’s multiple requests for more information.
According to the retraction notice in the International Journal of Molecular Medicine (IJMM), the authors intended that the two different papers offered “different research perspectives.”
Meanwhile, the Chinese Medical Journal — which published the same images one month later — has issued an expression of concern (EOC), noting it “should not be considered as a statement regarding the validity of the work.” Both papers describe how cells regulate blood flow to the retina.
Normally, journals choose to retract the most recent paper containing duplicated images, but in this case, the IJMM paper was published online in February 2016, and the Chinese Medical Journal in March.
According to an excerpt from the retraction notice in Genetics and Molecular Research, the journal has “strong reason to believe that the peer review process was [a] failure,” and has alerted the authors’ institutions.
According to the new retraction notice in The Plant Cell, some figures in the paper were manipulated, as well as “inappropriately duplicated and reused from a previous publication.” The authors assert that they believe the conclusions remain valid.
The journal has also issued two corrections that include some of the same authors — including one that cites inappropriate image manipulation.
Zhao Kai, the study’s first author from the Qilu Hospital of Shandong University and Zibo Central Hospital (both in China), took full responsibility for the error.
According to the retraction notice in the International Journal of Molecular Medicine, the reader showed the journal that the histological data in two of the figures were from another published paper by different researchers. But when the journal contacted the authors on several occasions, they didn’t hear back.
After the Journal of Medical Entomology (JME) published the study — about the identification of genes that enable an insect to detect odors — an outside researcher wrote a letter to the journal highlighting flaws in the paper. The journal then asked the authors to respond, and enlisted two additional peer reviewers to look into the study, the outside comment, and the authors’ response. They concluded the paper should be retracted.
William Reisen — the journal’s editor-in-chief from the University of California, Davis — said the journal believes the errors were unintentional and there was no fraud on the authors’ part. He added: Read the rest of this entry »
On December 31st 2014, a pioneer in the study of inflammatory bowel disease passed away. An obituary published in the Journal of Digestive Diseases shortly thereafter is typical enough: It describes his achievements, importance to his patients, and battle with pancreatic cancer.
But “Loss in the Last Day of 2014: a Eulogy for Prof. Bing Xia” has now been retracted.
This is the first time we’ve seen an obituary pulled from a journal. Unfortunately, this was not a case of a premature obituary (which happens more often than you’d think)– the researcher did actually die, but it appears the journal published the obituary in the wrong place.
The retraction notice, published earlier this year, explains: